Paper Boat Creative Quant Investment research and stock picks come from many places, but not all resources are created equal. Computer-driven strategies – the power of quantitative analysis and collecting and analyzing numerical data in a fraction of the time – offer investors the opportunity to instantly evaluate stocks to help avoid companies with poor…
Strainly, a cannabis seed and services company, in partnership with BTCPay has published a case study on the use of BTCPay to facilitate payment processing for underserved and blacklisted industries. One of the most important use cases of Bitcoin is, as many users of a certain privacy wallet would say, “To make the transactions they…
Unchained, a prominent Bitcoin financial services provider, released a new report today showcasing an interesting surge in bitcoin ownership among Americans. According to their findings, a one in four Americans and 55% of surveyed investors, defined by Unchained as those with at least one investment account between the ages of 18 and 78, own bitcoin. The…
FatCamera/E+ via Getty Images Rezolute – Overview Rezolute (NASDAQ:RZLT) is a clinical-stage biotechnology company focused on metabolic diseases relating to the control of glucose. The lead asset, RZ358, is a human monoclonal antibody that binds to an allosteric site on the insulin receptor and down-regulates the activity of the receptor. The down-regulation of the insulin…
lenscap67 Harmony Biosciences Overview Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a Pennsylvania-based, commercial stage pharmaceutical company that joined the Nasdaq back in August 2020, its initial public offering raising ~$148m, via the issuance of ~6.1m shares priced at $24. In fact, Harmony markets and sells a single product, WAKIX, which was approved by the FDA…
Natalya Bosyak/iStock via Getty Images At a Glance In light of new data from the PROTECT study, my previous caution on Travere Therapeutics (NASDAQ:TVTX) has intensified. Filspari’s mixed efficacy—significant in proteinuria reduction but inconclusive in pivotal eGFR total slope—casts doubt on its long-term clinical value. While the Mirum deal has shored up liquidity, extending the…
gerenme/iStock via Getty Images PDS Biotechnology Corporation (NASDAQ:PDSB) has been able to make great progress with respect to advancing the use of its lead candidate known as PDS0101, which is being developed in combination with Merck’s (MRK) Keytruda to treat certain patients with HPV16-positive head and neck cancer. The last time I spoke about this…
Supatman/iStock via Getty Images Everyone is talking about generative AI’s ability to impact businesses, but few have measured what companies are actually doing with this groundbreaking technology. That gap is now starting to be filled, thanks in part to an in-depth study by TECHnalysis Research that dives into the details of how US-based businesses are…